Scinovex
review Open AccessTop 1% cited

Extracellular vesicles as drug delivery systems: Why and how?

Advanced Drug Delivery Reviews · 2020 · Vol. 159 · pp. 332–343
Omnia M. ElsharkasyJoel Z. NordinDaniel W. HageyOlivier G. de JongRaymond M. SchiffelersSamir EL AndaloussiPieter Vader

Abstract

Over the past decades, a multitude of synthetic drug delivery systems has been developed and introduced to the market. However, applications of such systems are limited due to inefficiency, cytotoxicity and/or immunogenicity. At the same time, the field of natural drug carrier systems has grown rapidly. One of the most prominent examples of such natural carriers are extracellular vesicles (EVs). EVs are cell-derived membranous particles which play important roles in intercellular communication. EVs possess a number of characteristics that qualify them as promising vehicles for drug delivery. In order to take advantage of these attributes, an in-depth understanding of why EVs are such unique carrier systems and how we can exploit their qualities is pivotal. Here, we review unique EV features that are relevant for drug delivery and highlight emerging strategies to make use of those features for drug loading and targeted delivery.

Extracellular vesicles in diseaseMicroRNA in disease regulationRNA Interference and Gene DeliveryDrug deliveryExtracellular vesiclesTargeted drug deliveryExtracellular vesicleNanotechnologyExploitDrugMicrovesiclesDrug carrierChemistry

MeSH terms

Extracellular VesiclesAnimalsHumansDrug Delivery Systems

Funding

  • European Commission
Citations
1,147
FWCI
53.56
field-weighted impact
References
138
Percentile
100%
vs. same field & year
Citations per year
Cited by
Emerging concepts of miRNA therapeutics: from cells to clinic
Trends in Genetics · 2022 · 902 citations
Extracellular vesicles as a next-generation drug delivery platform
Nature Nanotechnology · 2021 · 1,756 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.